Omega Therapeutics, INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
FMR LLC and its affiliate Abigail P. Johnson have filed an amended Schedule 13G, reporting a complete divestment of their beneficial ownership in Omega Therapeutics Inc., reducing their stake to 0.0%.